Bridge Funding For IPO

Maximum Amount: On Request
Funding Source Details
Listed on Apr 4, 2025(Renewed on Nov 18, 2025)

Bridge funding NASDAQ / NYSE IPO or European Direct Listings – Covering Listing Costs (Excluding PCAOB Audit for US listing):

Artificial Intelligence & Machine Learning
We are seeking companies applying AI/ML to real-world applications with strong market potential, including but not limited to:

Generative AI platforms and tools (e.g. LLMs, AI copilots)

AI infrastructure (semiconductors, edge computing, model optimization)

Industry-specific AI (healthcare, logistics, enterprise automation)

Synthetic data, AI governance & security

Biotechnology & Pharma
We are focused exclusively on cutting-edge, late-stage companies in:

Immunology & oncology (Phase II/III preferred)

Orphan drugs / rare disease therapeutics (FDA Orphan Drug Designation a plus)

Cell & gene therapies with clinical data

Neurodegenerative diseases, CNS, and psychiatric indications

Vaccine platforms targeting unmet medical needs

Green & Sustainable Technologies
We welcome companies developing impactful climate and sustainability solutions, including:

Renewable energy generation (solar, wind, geothermal)

Energy storage technologies (next-gen batteries, hydrogen)

Carbon capture, utilization, and storage (CCUS)

Circular economy, advanced recycling, and waste-to-energy

Sustainable materials and green construction tech

Nuclear module stations

Cybersecurity
We are actively seeking B2B cybersecurity companies with scalable platforms, such as:

Cloud-native security

Zero Trust architecture

Threat detection & response (XDR, SIEM)

Secure access & identity management (IAM)

AI-driven threat intelligence

Neurotech & Psychedelic Therapies
We are interested in companies developing breakthrough treatments for mental and neurological disorders:

Psychedelic-assisted therapies (e.g. psilocybin, ketamine) in clinical stages

Devices and neurostimulation technologies

Digital therapeutics targeting depression, anxiety, PTSD

CNS drug development with measurable patient outcomes

Aerospace & Defense Tech
Focus areas include companies at the intersection of commercial innovation and strategic defense:

Small satellite constellations & space infrastructure

Dual-use drone & surveillance technologies

AI-enhanced defense systems

Communications & cybersecurity in aerospace applications

PLEASE ENQUIRE ONLY IF YOU ARE READY TO SIGN AN NDA AND START THE DUE DILLEGENCE PROCESS.

change currency

Financials (USD)

Maximum Amount Not Disclosed

Converted From EUR

Exchange Rate $1.17

Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum. Read DealStream's Terms Of Use before responding to any listing. Learn how to stay safe in our marketplace.

Request Information

Want to learn more about this listing? Log in now. New to DealStream? Discover how artificial intelligence can help you find better deals! Sign up for a Free Account today and get your first Search Genius deal tomorrow.

Sign Up

DealStream Awards & Reviews

More Listings Like This
Resources For Entrepreneurs